
|Videos|November 14, 2020
AAO 2020: Study confirms Phase III results for uveitis treatment
Author(s)OT Staff Reports
Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.
Advertisement
Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Avacincaptad pegol analysis links GA treatment to preserved driving vision
2
QA102 data suggest signal in intermediate dry AMD, but insignificant drusen volume change
3
No 'smoking gun' OCT biomarker found for DME outcomes: Insights from Protocol T
4
Tinlarebant earns Swiss orphan drug status for Stargardt disease
5























